AU2297792A - Therapeutic polypeptides based on von willebrand factor - Google Patents

Therapeutic polypeptides based on von willebrand factor

Info

Publication number
AU2297792A
AU2297792A AU22977/92A AU2297792A AU2297792A AU 2297792 A AU2297792 A AU 2297792A AU 22977/92 A AU22977/92 A AU 22977/92A AU 2297792 A AU2297792 A AU 2297792A AU 2297792 A AU2297792 A AU 2297792A
Authority
AU
Australia
Prior art keywords
von willebrand
willebrand factor
therapeutic polypeptides
polypeptides based
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU22977/92A
Inventor
Michael N. Chang
Daniel G. Mcgarry
John R. Regan
Zaverio M. Ruggeri
Jerry L Ware
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Rhone Poulenc Rorer International Holdings Inc
Original Assignee
Rhone Poulenc Rorer International Holdings Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer International Holdings Inc filed Critical Rhone Poulenc Rorer International Holdings Inc
Publication of AU2297792A publication Critical patent/AU2297792A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU22977/92A 1991-06-28 1992-06-29 Therapeutic polypeptides based on von willebrand factor Abandoned AU2297792A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72058891A 1991-06-28 1991-06-28
US720588 1996-09-30

Publications (1)

Publication Number Publication Date
AU2297792A true AU2297792A (en) 1993-01-25

Family

ID=24894560

Family Applications (1)

Application Number Title Priority Date Filing Date
AU22977/92A Abandoned AU2297792A (en) 1991-06-28 1992-06-29 Therapeutic polypeptides based on von willebrand factor

Country Status (3)

Country Link
AU (1) AU2297792A (en)
MX (1) MX9203763A (en)
WO (1) WO1993000357A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU677659B2 (en) * 1993-04-23 1997-05-01 Bio-Technology General Corporation Method of enhancing thrombolysis

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5900476A (en) * 1986-05-30 1999-05-04 The Scripps Research Institute Therapeutic domains of van Willebrand factor
WO1992017192A1 (en) * 1991-03-27 1992-10-15 The Scripps Research Institute Therapeutic fragments of von willebrand factor
FR2686901A1 (en) * 1992-01-31 1993-08-06 Rhone Poulenc Rorer Sa NOVEL ANTITHROMBOTIC POLYPEPTIDES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
US5709180A (en) * 1997-02-06 1998-01-20 General Motors Corporation Narrow cam two-step lifter
US7349393B2 (en) * 1999-12-02 2008-03-25 Verizon Business Global Llc Method and system for implementing an improved universal packet switching capability in a data switch
PT1835938E (en) 2004-12-27 2013-11-06 Baxter Int Polymer-von willebrand factor-conjugates
US7645860B2 (en) 2006-03-31 2010-01-12 Baxter Healthcare S.A. Factor VIII polymer conjugates
EP2010222A1 (en) 2006-03-31 2009-01-07 Baxter International Inc. Pegylated factor viii

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU677659B2 (en) * 1993-04-23 1997-05-01 Bio-Technology General Corporation Method of enhancing thrombolysis

Also Published As

Publication number Publication date
WO1993000357A1 (en) 1993-01-07
MX9203763A (en) 1993-08-01

Similar Documents

Publication Publication Date Title
AU3588189A (en) Polypeptide compounds
AU3414689A (en) Therapeutic peptides
AU3977589A (en) Novel peptides
AU3108389A (en) Polypeptides
AU3724093A (en) Vaccinal polypeptides
GB9315303D0 (en) Polypeptide
AU2297792A (en) Therapeutic polypeptides based on von willebrand factor
AU4271793A (en) Novel polypeptide
AU3130793A (en) Collagen-like polypeptides
EP0648268A4 (en) Therapeutic fragments of von willebrand factor.
AU1314492A (en) Chimaeric polypeptides
AU4022589A (en) Vaccinal Polypeptides
AU3597289A (en) D-cys6 vasopressin antagonists
AU3231189A (en) Recombinant endonexin ii
AU9069591A (en) Therapeutic fragments of von willebrand factor
AU1198192A (en) Novel peptide
AU1707892A (en) Gastrin-binding protein
AU6528790A (en) Recombinant human thrombomodulin
AU689799C (en) Recombinant retroviruses
AU4594493A (en) New polypeptide
AU640347C (en) Vaccinal Polypeptides
GB9125931D0 (en) Polypeptides
GB9117985D0 (en) Polypeptides
GB9102799D0 (en) Polypeptides
AU7592594A (en) Recombinant retroviruses